Cite
HARVARD Citation
Im, S. et al. (n.d.). 39OPooled analysis of efficacy and safety in Asian patients (pts) in the MONALEESA-2, MONALEESA-3, and MONALEESA-7 trials of ribociclib (RIB) plus endocrine therapy (ET). Annals of oncology. p. . [Online].